PI
ALNA

Pharmstandard International’s Allena Pharmaceuticals ALNA Stock Holding History

Pharmstandard International’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$9.38M Sell
873,031
-5,100
-0.6% -$56.1K 32.28% 1
2018
Q2 		$11.4M Sell
878,131
-159,136
-15% -$2.29M 45.89% 1
2018
Q1 		$11.4M Hold
1,037,267
– – 28.71% 2
2017
Q4 		$10.4K Buy
+1,037,267
New +$12.8M 10.73% 4

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PIM
Partner Investment Management San Francisco, California $13.9M AUM 55.92% 1-Year Est. Return

Pharmstandard International's ALNA Position: Q3 2018 in Review

Pharmstandard International reduced its Allena Pharmaceuticals (ALNA) stake by 0.58% in Q3 2018, selling an estimated $56.1K and leaving 873,031 shares worth $9.38M. The position accounts for 32.28% of the portfolio, ranked #1.

Pharmstandard International first reported a position in ALNA in Q4 2017 and has held it in 4 quarters since. The position peaked at $11.4M in Q2 2018. 46 funds tracked by Wall St. Rank hold ALNA as of Q3 2018.

  • Pharmstandard International held 873,031 shares of Allena Pharmaceuticals worth $9.38M as of Q3 2018.
  • Pharmstandard International sold 5,100 Allena Pharmaceuticals shares in Q3 2018, an estimated $56.1K.
  • Allena Pharmaceuticals made up 32.28% of Pharmstandard International's portfolio in Q3 2018, its #1 holding.
  • Pharmstandard International first reported a position in Allena Pharmaceuticals in Q4 2017 and has held it in 4 quarters since.
  • Pharmstandard International's Allena Pharmaceuticals position peaked at $11.4M in Q2 2018.
  • 46 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2018.

Based on Pharmstandard International's 13F filing for Q3 2018, filed 15 Nov 2018.